EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Actinium-225 targeted alpha particle therapy for prostate cancer

Anil P Bidkar, Luann Zerefa, Surekha Yadav, Henry F VanBrocklin, Robert R Flavell

Theranostics · 2024 · 14 (7) · 2969-2992

DOI: 10.7150/thno.96403 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, 2024. Verfasst von Anil P Bidkar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Biomedical Imaging, University of California San Francisco, CA-94107, USA. Hauptthemen laut MEDLINE: Actinium, Prostatic Neoplasms, Alpha Particles. Die Arbeit wurde bisher 97-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ActiniumProstatic NeoplasmsAlpha ParticlesHumansMaleRadiopharmaceuticalsAnimals

Stichwörter der Autor:innen

Actinium-225alpha particle therapyprostate cancertargeted alpha therapy

Substanzen

ActiniumRadiopharmaceuticalsActinium-225

Autor:innen und Institutionen

  • Department of Radiology and Biomedical Imaging, University of California San Francisco, CA-94107, USA.
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA-94107, USA.
  • Department of Pharmaceutical Chemistry, University of California, San Francisco, CA-94107, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Bidkar, A. P., Zerefa, L., Yadav, S., VanBrocklin, H. F., & Flavell, R. R. (2024). Actinium-225 targeted alpha particle therapy for prostate cancer. Theranostics, 14(7), 2969-2992. https://doi.org/10.7150/thno.96403

Vancouver

Bidkar AP, Zerefa L, Yadav S, VanBrocklin HF, Flavell RR. Actinium-225 targeted alpha particle therapy for prostate cancer. Theranostics. 2024;14(7):2969-2992. doi:10.7150/thno.96403

BibTeX
@article{Bidkar2024,
  author = {Bidkar, Anil P and Zerefa, Luann and Yadav, Surekha and VanBrocklin, Henry F and Flavell, Robert R},
  title = {Actinium-225 targeted alpha particle therapy for prostate cancer},
  journal = {Theranostics},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {2969--2992},
  doi = {10.7150/thno.96403}
}
Kostenlos starten →